CDK5 downregulation enhances synaptic plasticity.
Rafael Andrés Posada-DuqueOmar RamirezSteffen HärtelNibaldo C InestrosaFelipe BodaleoChristian González-BillaultAlfredo KirkwoodGloria Patricia Cardona-GómezPublished in: Cellular and molecular life sciences : CMLS (2016)
CDK5 is a serine/threonine kinase that is involved in the normal function of the adult brain and plays a role in neurotransmission and synaptic plasticity. However, its over-regulation has been associated with Tau hyperphosphorylation and cognitive deficits. Our previous studies have demonstrated that CDK5 targeting using shRNA-miR provides neuroprotection and prevents cognitive deficits. Dendritic spine morphogenesis and forms of long-term synaptic plasticity-such as long-term potentiation (LTP)-have been proposed as essential processes of neuroplasticity. However, whether CDK5 participates in these processes remains controversial and depends on the experimental model. Using wild-type mice that received injections of CDK5 shRNA-miR in CA1 showed an increased LTP and recovered the PPF in deficient LTP of APPswe/PS1Δ9 transgenic mice. On mature hippocampal neurons CDK5, shRNA-miR for 12 days induced increased dendritic protrusion morphogenesis, which was dependent on Rac activity. In addition, silencing of CDK5 increased BDNF expression, temporarily increased phosphorylation of CaMKII, ERK, and CREB; and facilitated calcium signaling in neurites. Together, our data suggest that CDK5 downregulation induces synaptic plasticity in mature neurons involving Ca2+ signaling and BDNF/CREB activation.
Keyphrases
- cell cycle
- cell proliferation
- protein kinase
- long non coding rna
- wild type
- signaling pathway
- long noncoding rna
- spinal cord
- spinal cord injury
- type diabetes
- brain injury
- stress induced
- electronic health record
- mouse model
- high glucose
- oxidative stress
- blood brain barrier
- subarachnoid hemorrhage
- diabetic rats
- ultrasound guided